2016 Hematological Malignancies

963 / 1835

Halasz et al
• 59 pts, 2001 – 2008, mFU 3.9y
• All had PET (interim=50 &/or end=28) + RT
• 83% stage 1-2
• 98% RCHOP
• 22 pts had +ve PET
(7 iPET)
3y LC PFS Death
PET -ve 100% 97% 1 (2nd lymphoma)
PET +ve 90% 90% 1 (relapse)